S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01

Japan minister aims to control COVID while achieving growth

Wednesday, January 12, 2022 | Yuri Kageyama, AP Business Writer

Daishiro Yamagiwa
Japan's Minister for Economic Revitalization Daishiro Yamagiwa speaks during a press conference at the National Press Club on Wednesday, Jan. 12, 2022, in Tokyo. Assigned the task of containing COVID-19 while steering the world’s third largest economy toward growth, Yamagiwa said Japan must learn to coexist with the coronavirus. (AP Photo/Eugene Hoshiko)

TOKYO (AP) — The Japanese minister responsible for containing COVID-19 while steering the world’s third largest economy toward growth says he is confident he can carry out that precarious “balancing act.”

“We know infectious diseases aren’t going away ever,” Daishiro Yamagiwa said Wednesday at the Japan National Press Club in Tokyo. “Co-existing with them while revitalizing the economy toward growth is our job,” he said.

Japan had managed to cut new infections to very low levels last fall, then loosening precautions mean to keep the virus at bay. But medical experts warn it should expect a surge of COVID infections in the next few weeks. Daily reported cases are totaling several thousand nationwide, roughly tripling from last week.

Japan has responded flexibly against its “invisible enemy," setting up a system of quarantines at home for those sick with the omicron variant of coronavirus, instead of hospitalization for all, and speeding up vaccine boosters, said Yamagiwa, a veterinarian and graduate of the prestigious Yamaguchi University.

Boosters have lagged in Japan, compared to the U.S., South Korea and parts of Europe. Although about 80% of Japanese have received two shots, fewer than 1% have gotten a booster.

Most people are not expected to get booster shots until after March, possibly weeks or months longer than the recommended six-month gap after the second COVID-19 shot.

Critics have long said Japan needs to break out of entrenched bureaucracy and vested interests to reinvent itself and become more dynamic and competitive.

Yamagiwa said Japan needs to nurture digital technology, artificial intelligence, sustainability and biotechnology to break out of the decades-old doldrums that have worsened with the pandemic.

The Japanese economy is expected to grow in the current fiscal year, which ends in March, after contracting last year. But the latest wave of infections adds to uncertainty.

“Like many other countries in Asia, Japan’s latest GDP data demonstrate that COVID is still exerting a strong influence on the economy,” said Robert Carnell, regional head of research, at ING, noting restrictions on people’s activity have dampened spending, trade and investment.

The government recently ordered restrictions in Okinawa, Yamaguchi and Hiroshima prefectures, where COVID surges have been most serious.

Throughout his presentation, Yamagiwa returned to the theme of Prime Minister Fumio Kishida's “new capitalism” platform.

While critics say it's just a slogan and is scarce on specifics. Yamagiwa said the government will work to raise wages, invest in people and nurture startups and research.

He acknowledged Japan has fallen behind other leading economies in digitization, market capitalization of companies and even Nobel laureates.

But he said Japan had what he called “moonshot” goals, including leading the world in avatar technology by 2050 and investing in a Japanese university so it "becomes a Stanford.”

“Japan will become No. 1 in the world,” he said.


Yuri Kageyama is on Twitter https://twitter.com/yurikageyama

7 Manufacturing Stocks That Will Overcome Current Difficulties

The manufacturing industry was one of the hardest hits in 2020. In the initial months of the coronavirus pandemic, many companies were forced to shutter operations. However, opportunistic investors kept their eye on several of these companies as recovery stocks. And at the beginning of 2021, the emergence of several vaccines allowed businesses to reopen.  Not surprisingly, manufacturing stocks were among the biggest winners.

But where are these stocks headed in 2022? In December, American manufacturers reported their slowest pace of growth in 11 months. A closely followed index of U.S.-based manufacturers dropped to 58.7% in the final month of 2021. This was slightly lower than the 61.1% in November according to the Institute for Supply Management.

Still, any number of above 50% signals expansion. And the number is only slightly below the 60% level that signifies exceptional growth.

Ironically, it’s the virus that continues to provide a headwind. Supply chains are unwinding but not nearly fast enough to prevent material shortages. The controversy surrounding vaccine mandates is causing labor shortages.

However, there’s a strong likelihood that manufacturing stocks will have a strong year in 2022. And even if they don’t, many of these stocks pay a reliable dividend. That’s why we’ve put together this special presentation on the manufacturing stocks that will overcome current difficulties.

View the "7 Manufacturing Stocks That Will Overcome Current Difficulties".


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.